JP Stock MarketDetailed Quotes
4594 BrightPath Biotherapeutics
- 56
- +2+3.70%
20min DelayMarket Closed Nov 22 15:30 JST
4.69BMarket Cap-3075P/E (Static)
56High52Low2.13MVolume54Open54Pre Close113.56MTurnover10052wk High2.72%Turnover Ratio83.79MShares4152wk Low-16.51EPS TTM4.39BFloat Cap2229Historical HighLossP/E (Static)78.32MShs Float41Historical Low-18.21EPS LYR7.41%Amplitude--Dividend TTM3.87P/B100Lot Size--Div YieldTTM
About BrightPath Biotherapeutics Company
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
Company Profile
Symbol4594
Company NameBrightPath Biotherapeutics
Founded2003-05-08
MarketTSE Growth
Fiscal Year Ends03-31
Address2-2-4 Kojimachi Kojimachi Central Building 7th Floor
Zip Code102-0083
Phone03-5840-7697
Websitewww.brightpathbio.com
Company Executives
- Name
- Position
- Salary
- Yoichi Takeshita
- Director and Chief Financial Officer
- --
- Kenichi Nagai
- Representative Director and President
- --
- Tokuhiro Nakamura
- Director and Director of Drug Discovery Research
- --
- Ryo Yamada
- Director
- --
- Hirotaka Takeuchi
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data